Sunil M. Malkani v. Gemma Cunningham a/k/a Gemma Turi

CourtCourt of Chancery of Delaware
DecidedFebruary 27, 2024
DocketC.A. No. 2020-1004-SG
StatusPublished

This text of Sunil M. Malkani v. Gemma Cunningham a/k/a Gemma Turi (Sunil M. Malkani v. Gemma Cunningham a/k/a Gemma Turi) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sunil M. Malkani v. Gemma Cunningham a/k/a Gemma Turi, (Del. Ct. App. 2024).

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

SUNIL M. MALKANI, NICHOLAS ) MATARAGAS, and RED DRAGON ) PARTNERS, LLC, ) ) Plaintiffs, ) ) v. ) C.A. No. 2020-1004-SG ) GEMMA CUNNINGHAM a/k/a ) GEMMA TURI, CHARLES D. ROSEN, ) GARY WILSON, and TRUTHMD, LLC, ) a Delaware limited liability company, ) ) Defendants. )

MEMORANDUM OPINION

Date Submitted: November 8, 2023 Date Decided: February 27, 2024

Philip Trainer, Jr., Marie M. Degnan, and Randall J. Teti, ASHBY & GEDDES, Wilmington, Delaware; OF COUNSEL: Marcos D. Jimenez, MARCOS D. JIMENEZ, P.A., Miami, Florida, Attorneys for Plaintiffs.

Ryan P. Newell, Lakshmi A. Muthu, Tara C. Pakrouh, and Michael A. Carbonara, Jr., YOUNG CONAWAY STARGATT & TAYLOR, LLP, Wilmington, Delaware; Michael C. Heyden, Jr. and Joseph E. Brenner, GORDON REES SCULLY MANSUKHANI, LLP, Wilmington, Delaware, Attorneys for Defendants.

GLASSCOCK, Vice Chancellor This matter involves contract rights of an investor, Plaintiff Sunil Malkani, in

a Delaware LLC, Defendant TruthMD. The rights at issue are primarily embodied

in a set of agreements, the “March 13 Consolidation.” After a trial, I held in favor

of Malkani of the enforceability of those agreements, notwithstanding Defendants’

position—that Malkani had no contractual rights as an equity investor in TruthMD,

and that the March 13 Consolidation was unexecuted and unenforceable.

Defendants prevailed on a collateral issue, concerning Malkani’s present right to

veto a change in control transaction, which proved to be unripe.

Both parties seek their fees under a contractual fee shifting agreement

embodied in two agreements in March 13 Consolidation. That provision shifts

attorney fees to the prevailing party from the losing party. I find that Malkani,

having established the validity of the March 13 Consolidation and securing his rights

thereunder, is the prevailing party, entitled to his reasonable attorney’s fees in this

action. A full explanation of my reasoning is below.

1 I. BACKGROUND

A. Factual Background

The underlying proceeding in this action concerned an enforcement of a

contract between a private investor and a Delaware LLC.1 In 2016, Malkani

purchased three Series E preferred units for $498,000.2 From 2017 to 2020, the

parties negotiated investment terms piecemeal as Malkani invested money into

TruthMD.3 TruthMD and Malkani, through counsel, negotiated an arrangement to

consolidate Malkani’s prior advances and ease his future loans to TruthMD.4 These

negotiations led to TruthMD and Malkani entering into three agreements: the

purchase agreement (the “Purchase Agreement”), note (the “Note”), and nine-unit

warrant (the “Nine-Unit Warrant”) (collectively, the “March 13 Consolidation”).5

The Purchase Agreement contained a change-in-control provision, which provides

in part that “[t]he Company shall not change its ownership, control or management

structure . . .” without Malkani's prior written consent.6 The Purchase Agreement

1 This memorandum opinion is a brief recitation of facts and includes only those necessary to my analysis. For an in-depth version of the facts in the underlying proceedings, I will refer the reader to my January 31, 2023 Memorandum Opinion. Malkani v. Cunningham, 2023 WL 1383938 (Jan. 31, 2023) (“Mem. Op.”). 2 Id. at *1. 3 Id. at *2–5. 4 Id. at *4. 5 Id. 6 Id. at *2.

2 and Nine-Unit Warrant contain fee-shifting provisions for attorneys’ fees and are

governed by Delaware law.7

Section 10.10 of the Purchase Agreement provides:

Attorneys’ Fees. In the event that any dispute among the parties to this Agreement should result in litigation, the prevailing party in such dispute shall be entitled to recover from the losing party all fees, costs and expenses of enforcing any right of such prevailing party under or with respect to this Agreement, including without limitation, such reasonable fees and expenses of attorneys and accountants, which shall include, without limitation, all fees, costs and expenses of appeals.8

Section 9(i) of the Nine-Unit Warrant similarly provides:

In the event that any dispute among the parties to this Warrant should result in litigation, the prevailing party in such dispute shall be entitled to recover from the losing party all fees, costs and expenses of enforcing any right of such prevailing party under or with respect to this Warrant, including without limitation, such reasonable fees and expenses of attorneys and accountants, which shall include, without limitation, all fees, costs and expenses of appeals.9

After the parties entered the March 13 Consolidation, TruthMD entered into

an agreement for the potential acquisition of the Company.10 Malkani voiced

complaints about the transaction, after learning about the acquisition’s structure,

claiming that it was an attempt to line pockets of certain Board members and dilute

his equity interest.11 After receiving Malkani’s comments, TruthMD refused to

7 Pl. Mot. for Att’ys’ Fees 3, Dkt. No. 211; Def. Mot. for Att’ys’ Fees & Opp’n 3, Dkt. No. 215. 8 Exs. A-B to Pl. Sunil M. Malkani’s Mot. for Att’ys’ Fees, Costs, and Expenses, Ex. A § 10.10, Dkt. No 211 (emphasis added). 9 Id. at Ex. B § 9(i) (emphasis added). 10 Mem. Op. 5. 11 Id.

3 recognize his rights.12 This action, the substantive parts of which I have already

decided, followed.

B. Procedural History

The initial complaint in this matter was filed on November 21, 2020,13 and an

amended complaint was filed on June 28, 2021.14 Plaintiffs asserted claims against

Defendants for the following: (Count I) breach of fiduciary against board members

arising from the structure of the Company’s acquisition; (Count II) specific

performance for delivery of a warrant for three additional equity units; (Count III)

declaratory judgment that the March 13 Consolidation was valid and enforceable;

and (Count IV) breach of contract with respect to the change-in-control provision

contained in the Purchase Agreement.15

The action was bifurcated and a trial on Counts II-IV was held in April 2022.16

After receiving post-trial briefing and hearing arguments, I denied Counts II and IV,

but granted Count III.17 On Count II, I held that Malkani did not produce clear and

convincing evidence that he exceeded $2 million in funding for the additional three-

unit warrant.18 In determining Count IV, I found that Malkani’s claim for breach of

12 Id. 13 See Pls.’ Opening Br. in Supp. of Mot. for a TRO, Dkt. No. 1; see also Pls.’ Mot. for Expedited Proceedings, Dkt. No. 1. 14 Pls.’ Verified Am. Compl., Dkt. No. 84 (“Am. Compl.”). 15 Mem. Op. *6. 16 Id. 17 Id. at *6–11. 18 Id. at *9–10.

4 the change-in-control provision was unripe since there was not an imminent

acquisition that would constitute a breach of the provision, and the provision did not

prevent Defendant from seeking potential acquirers or engaging in negotiations.19

Finally, in analyzing Count III, I held that the Nine-Unit Warrant, Note, and

Purchase Agreement, which comprised the March 13 Consolidation, were valid and

enforceable.20

Additionally, I held that the parties’ attorney fee requests were premature

considering that the action was bifurcated and Count I remained to be tried in the

future.21 I deferred consideration of the issue pending resolution of Count I and any

additional disputes between the parties.22 On April 21, 2023, the parties stipulated

to dismissal of Count I without prejudice, making the fee issue ripe for decision.23

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Mahani v. Edix Media Group, Inc.
935 A.2d 242 (Supreme Court of Delaware, 2007)
Estate of Osborn Ex Rel. Osborn v. Kemp
991 A.2d 1153 (Supreme Court of Delaware, 2010)
Chrysler Corporation v. Dann
223 A.2d 384 (Supreme Court of Delaware, 1966)

Cite This Page — Counsel Stack

Bluebook (online)
Sunil M. Malkani v. Gemma Cunningham a/k/a Gemma Turi, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sunil-m-malkani-v-gemma-cunningham-aka-gemma-turi-delch-2024.